Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03010319 · ClinicalTrials.gov registry record · NA
PriMatrix for the Management of Diabetic Foot Ulcers
A NA study, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT03010319 is a NA study that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 226 participants.
The verdict
NCT03010319, a NA study, has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The study will evaluate the efficacy of PriMatrix Dermal Repair Scaffold in the management of diabetic foot ulcers in subjects with diabetes mellitus versus the Standard of Care treatment. Half of patients will be treated using PriMatrix while the other half will receive Standard of Care treatment.
Interventions
- DEVICE PriMatrix Dermal Repair Scaffold
- DEVICE Secondary Dressings
- DEVICE Offloading device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03010319
The ClinicalTrials.gov registry entry for NCT03010319 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PriMatrix Dermal Repair Scaffold is the first listed.
NCT03010319 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03010319 about?
NCT03010319 is a clinical study titled "PriMatrix for the Management of Diabetic Foot Ulcers". The study will evaluate the efficacy of PriMatrix Dermal Repair Scaffold in the management of diabetic foot ulcers in subjects with diabetes mellitus versus the Standard of Care treatment. Half of patients will be treated using PriMatrix while the other half will receive Standard of Care treatment.
What is the current status of trial NCT03010319?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2017-01. Estimated completion is 2020-08.
What interventions are being tested in trial NCT03010319?
The interventions under investigation include: PriMatrix Dermal Repair Scaffold (DEVICE), Secondary Dressings (DEVICE), Offloading device (DEVICE).
Who is sponsoring clinical trial NCT03010319?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.